Targeting altered drug targets is essential because traditional chemotherapy often affects both cancerous and healthy cells, leading to significant side effects. By focusing on the unique alterations in cancer cells, targeted therapies can reduce collateral damage to normal cells and improve treatment efficacy. This precision medicine approach enhances patient outcomes and minimizes adverse effects.
